University of Otago researchers have discovered that high-intensity exercise can reduce or reverse the loss in heart function caused by type 2 diabetes.
Researchers at the University of Georgia have shown that a simple intervention -- daily self-weighing -- can help people avoid holiday weight gain.
Children with type 1 diabetes find it difficult to adhere to their drug routines during school holidays and weekends. Holiday distractions cause a 20% reduction in adherence to taking medications that assist managing their condition and other associated conditions, which may have serious consequences for their health.
A new study has investigated how exposure to certain triggers can increase the risk of type 1 diabetes.
An international consortium of scientists has analyzed protein-coding genes from nearly 46,000 people, linking rare DNA alterations to type 2 diabetes. The study, one of the largest known of its type, includes data from people of European, African American, Hispanic/Latino, East Asian, and South Asian ancestries. From this large cohort the researchers identified four genes with rare variants that affect diabetes risk. The data suggests that hundreds more genes will likely be identified in the future.
Researchers at University of Utah Health have identified a way to control the production of white fat using TLE3, a genetic switch that stops the conversion of white fat into beige fat.
By understanding how the brain links the effects of insulin to light, researchers (UNIGE) are deciphering how insulin sensitivity fluctuates according to circadian cycles. At the heart of their discovery are neurons of the ventromedial hypothalamic nucleus, a part of the brain that masters this balance. These results should also encourage diabetic patients to consider the best time to take insulin to properly control its effect and limit the risk of hypoglycemia.
A new study from Joslin Diabetes Center has proven that certain biological protective factors play a large role in preventing diabetic kidney disease in certain people. The study was published today in Diabetes Care.
A new discovery made mainly in mice could provide new options for getting the insulin-making 'factories' of the pancreas going again when diabetes and obesity have slowed them down. It could offer new pathways to ramping up insulin supply to get metabolism back on track in people with Type 1 and Type 2 diabetes, and obesity.
SR9009 is a compound that can lead to a wide range of health benefits in animals, including reduced risk of obesity and type 2 diabetes. Until now, researchers have attributed the effects to SR9009's role in altering the body's circadian clock. However, in a first-of-its-kind study from Penn Medicine, researchers found that SR9009 can effect cell growth and metabolic function without the involvement of REV-ERBs.